Role of Antibotics
Role of Antibotics
Role of Antibotics
net/publication/266968828
CITATIONS READS
5 6,777
1 author:
Akilesh Ramasamy
All India Insititute of Medical Sciences Gorakhpur
17 PUBLICATIONS 5 CITATIONS
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
Three-Dimensional Treatment Planning Digitised Workflow for Cranio-Maxillofacial Surgeries View project
All content following this page was uploaded by Akilesh Ramasamy on 16 October 2014.
akident@gmail.com
Abstract
Dentists commonly prescribe antibiotics for controlling and treating
dental infections. But there is a widespread abuse of antibiotics in
medical and dental field. The inappropriate use of antibiotics results
in increased treatment costs, increased risk of adverse events related
to the antibiotic used and most importantly development and propa-
gation of antimicrobial resistance. The definitive indications for use of
antibiotics in dentistry are limited and specific. This review discusses
the various principles and rationale behind antibiotic therapy in differ-
ent fields of dentistry with stress on rational antibiotic use in dentistry
Introduction
Dentistry is a comprehensive speciality devoted to resolving dental
infections or restoring and rehabilitating tooth structure lost to such
bacterial processes. The use of antibiotics is an integral part of den-
tistry and prescribing antibiotics is a privilege that must not be abused.
Irrational use of antibiotics will lead to an increased burden on the
patient and the society by increasing treatment costs, adverse events
and also the risk of development of resistant bacterial species. Anti-
biotic abuse has already been considered as a pandemic community
issue by World Health Organization (WHO) [1], whilst the abuse of
antibiotics by dentists is worldwide as shown by many reports [2–5].
The oral cavity is a complex biological ecosystem with very large num-
ber of organisms living in a biofilm [6]. The interaction of the organisms
are complex and the change from health to disease state is associ-
© Under License of Creative Commons Attribution 3.0 License This article is available from: www.iajaa.org 1
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
ated with a change in the balance of the ecosystem result in prompt relief of pain as well as the infec-
usually from the resident facultative anaerobes to tion. Antibiotics do not contribute to pain relief as
obligate anaerobes for most pulpal and periodontal they have no action on the inflammatory process
diseases [7]. Even though only a few of the micro- that causes the pain [9–11]. With appropriate mea-
organisms cause odontogenic infections, in disease sures to remove the foci of infection, antibiotics are
state, many other non pathogenic bacterial species not necessary in most cases. An old surgical credo
contribute by maintaining an ecosystem favourable is “pus cannot be cured by penicillin”.
for survival and growth of the pathogenic species.
The onset of disease is due to a shift in microbial
flora. Understanding this ecological principle is im- Principles of antibiotic usage
portant while treating oral and dental infections.
Micro-organisms in a biofilm are consistently more In recent times, antimicrobial stewardship has been
resistant to usual dosage of antibiotics by 1000- given lots of importance at the patient level and at
1500 fold [8]. the community level. Antimicrobial stewardship is
defined as “the optimal selection, dosage, and du-
Management of odontogenic infections involves ration of antimicrobial treatment that results in the
three phases; diagnosis, infection control and re- best clinical outcome for the treatment or preven-
habilitation/restoration. Antibiotics are useful in the tion of infection, with minimal toxicity to the patient
infection control phase. Based on the data collected and minimal impact on subsequent resistance.” Jo-
and interpreted in the diagnostic phase, infection seph and Rodvold [12] summarised the 4 D's of an-
control phase involves removal of the infectious foci timicrobial therapy which is given in Table 1. An
and resolving the infection. This will include use important consideration in starting antimicrobial
of antibiotics/antiseptic agents as well as surgical therapy is to assess if the infection is localized and
methods to resolve the infection. Until resolution of if the patient has an adequate immune response to
the infection, the response to the treatment should control the bacteria if supported surgically. These
be assessed often. considerations are summarised in Table 2.
Most dental pain is the result of infection induced In the presence of purulence, signs of inflamma-
inflammatory process in a closed compartment as tion, abscess or draining sinus tracts, the lesion/
in the pulp and the apical periodontal region or in infection responds to local debridement measures
sensitive and highly innervated soft tissue like the in a healthy patient [12,13]. In an otherwise healthy
periosteum space, gingiva and periodontium. The patient, infections that have not crossed the dento-
general principle of management of all infectious alveolar regions are amenable to treatment without
processes is the removal of the foci of infection.
Control of dental infections is by mechanical re-
moval of the foci of infection. It can be achieved Table 1. 4 D’s of antimicrobial therapy [12].
by removal of the infected pulp, scaling and root
planning and drainage of the pus by incision when right Drug
the soft tissue spaces are involved. Usually a com- right Dose
bination of one or more of these techniques are
De-escalation to pathogen-directed therapy,
utilised for maximum benefit. This, when supported
by appropriate use of anti-inflammatory agents can right Duration of therapy
2 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
4. A
s a prophylaxis in patients with systemic conditions like
rheumatic heart disease, endocarditis, heart / orthopaedic 4. Purulence – (Resolved by drainage of pus / debridement)
prosthesis.
antibiotics. The infections that are about to breach troduced in the market, there are a very few an-
the dentoalveolar regions and threaten to extend tibiotics that are useful in dental infections. Most
into deeper hard tissues or into the soft tissue fas- infections of dental origin still respond to penicillin
cial spaces in the head and neck region will need group of antibiotics [18] and routine use of newer
use of appropriate antibiotics along with surgical antibiotics only adds to the cost and risk of anti-
therapy [14–16]. biotic resistance to these agents. Aminopenicillins
are not active against anaerobes but odontogenic
infections that show anaerobic pathogenic bacteria
Antibiotics appropriate still respond to these antibiotics and these antibiot-
for dental use ics may act by changing the ecological niche that
will result in death of the pathogenic anaerobes as
Different antibiotic prescribing trends are in practice well. [13]. Adding a drug with anaerobic cover like
among dentists [4,5,17]. Understanding the phar- metronidazole has a synergistic effect. [19]. A list of
macokinetics and pharmacodynamics is important drugs useful in dentistry are listed in Table 3. Bacte-
for appropriate use of the antibiotics. In spite of ricidal antibiotics are preferred when the host is im-
a large of number of newer antibiotics being in- mune compromised as bacteriostatic drugs require
- Injectable drugs
- Active against gram negative odontogenic infections
Aminoglycosides Cidal/static - Used in combination with other drugs in severe
odontogenic infections
- Ototoxicity and hepatotixicity.
the host's immune system to completely eradicate starting any antibiotics. After collection of sample,
the infection [20]. treatment should be started immediately by use of
empiric antibiotics. For minor infections, amoxicillin
If the decision to prescribe an antibiotic is made, or amoxicillin/clavulanate is sufficient. A combina-
it may be necessary to use microbiological testing tion of beta-lactamase resistant penicillin group of
to choose the appropriate antibiotic. Microbiologi- drug and metronidazole is started in cases of seri-
cal testing by culture and sensitivity tests will help ous odontogenic infections along with appropriate
choose the best antibiotic. Samples are collected surgical therapy [16,19,21,22]. Routine culture and
in an appropriate manner after consultation with sensitivity are not recommended in minor odonto-
the lab and sent immediately, preferably before genic infections. These infections respond well to
4 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
empiric antibiotic therapy with penicillin group of their efficacy as there are no clear studies on the
drugs. It and so routine culture and sensitivity is not best dosages and frequencies as applicable to den-
cost effective [21]. In case of severe infections or tistry.
infections showing rapid spread, culture and sensi-
tivity might be recommended. One must remember Higher dose of antibiotic given for a shorter dura-
that “waiting is wasting” in these scenarios. Empiric tion are advocated in recent years [4 ]. This regimen
antibiotic therapy is started and later changed, if would avoid selection of antibiotic resistant species
necessary, based on culture and sensitivity reports. and the risk of allergy or adverse events are not
significantly raised for most dental specific antibiot-
ics. Selection of antibiotic resistant species is com-
Appropriate dosage/frequency mon after using lower dose of antibiotics for longer
and duration periods of time. But before this, the first question
to ask oneself is whether an antibiotic is indicated
Discussing the detailed pharmacology of these in that particular clinical setting in that particular
drugs is beyond the scope of this article but a brief patient [3].
discussion of an important pharmacological profile
of antibiotics may be helpful. A brief tabulation of management of most common
conditions treated by a dentist with their manage-
Antibiotics can have a concentration-dependent ment principles is listed in Table 4.
killing or a time-dependent killing. The concentra-
tion-dependent drugs cause bacterial death when
present above a particular concentration. Increasing Antibiotics In Endodontic
the concentration will result in faster killing. Thus a Practice
single high dose may suffice to achieve the effect.
e.g, metronidazole. Time-dependent drugs have Most endodontic practice deals with acute and
their best effect when present at therapeutic levels chronic pulpal and periapical pathologies. Evidence
for a particular period of time. The therapeutic level has shown that antibiotics have no effect on the
of the drug must be maintained for long periods to pain in case.[10,23,24] Antibiotics are not useful
achieve best effect. Increasing the concentration of in most endodontic infections because it is doubt-
the drug may have no effect on its efficacy. These ful that systemic antibiotics are able to achieve an
drugs may be better used by increasing the fre- adequate therapeutic concentration within the ne-
quency of administration rather than increasing the crotic pulp [25]. Meticulous endodontic technique
dose. Penicillin group of drugs belong to this profile by avoiding over instrumentation will avoid periapi-
[13]. This suggests the question of whether 250 mg cal infections and flare ups during the endodontic
of amoxicillin given 4 times a day is more beneficial therapies [26]. Pain during endodontic treatment
than 500 mg of amoxicillin given 3 times a day Or is can be avoided by careful instrumentation. Non-
250 mg of amoxicillin given thrice a day sufficient? steroidal anti-inflammatory drugs (NSAIDs) can be
And in each of these settings, what is the recom- helpful to obtain pain relief [27]. Where endodontic
mended duration of therapy ? Different prescribing treatment is not feasible or in patients with non-
trends are present without adequate evidence of restorable tooth, extraction of the tooth will resolve
- Debridement
NUG without systemic complications in
- Irrigation No
healthy patients.
- Scaling and root planing
-Debridement
NUG with systemic complications or in Yes. Metronidazole is first choice.
-Irrigation
immune compromised patients / ANUP / HIV Penicillin group of drugs may be
-Scaling and root planing
associated NUG/NUP additional adjuvants [35]
-Systemic Antibiotics
May be considered early in
Aggressive periodontal diseases / Refractory - Debridement
generalized aggressive periodontitis
periodontal conditions - Scaling and root planing
[91]
- Incision and Drainage
Localized abscess No
- Removal of foci of infection
- Incision and drainage
Fascial space infections Yes
- Removal of foci of infection
Complicated endodontic / periodontic
- Removal of foci of infection
lesions with signs of systemic spread of Yes
- Incision and drainage
infection /involvement of fascial spaces
Systemically compromised patients with Removal of foci of infection by any Yes (use of bactericidal drugs
immune defects appropriate means recommended)
*n
ot supported by strong high quality evidence, NUG Necrotizing Ulcerative Gingivitis, NUP – Necrotizing Ulcerative Periodontitis,
HIV – Human Immunodeficiency Virus
6 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
the infectious process. As for endodontic surgeries, While some authors suggest that after appropri-
they do not require use of antibiotics in healthy pa- ate and thorough mechanotherapy, microbial test-
tients usually, but may be used if deemed necessary ing should be undertaken before starting antibiotic
by the clinician. [3]. Postoperative anti-inflammatory therapy [13] the benefit of microbial testing has also
drugs will be sufficient to control pain. Postsurgical been questioned [34].
infection is not common after endodontic surgeries
[28–30]. Gingivitis and chronic periodontitis
Acute peri-radicular abscess is a common endodon- Gingivitis is a local infectious process and responds
tic infection. A recent review concluded that there well to local mechanotherapy and antibiotic therapy
is insufficient evidence to recommend use of anti- is contraindicated [35]. Routine use of systemic an-
biotics in cases of apical periodontitis or in acute tibiotics in treatment of chronic periodontitis is not
peri-radicular abscesses [11]. In the management of justified in normal healthy patients. The risks of sys-
acute peri-radicular abscesses, the abscess should temic antibiotics outweigh the benefits for use in
first be drained by performing a pulpectomy or periodontal diseases [13]. Periodontal pockets can
incision and drainage, and relieving any traumatic be treated by local irrigation of antiseptic / antibiotic
occlusion. If adequate drainage is achieved via inci- solutions. The removal of the calculus and infected
sion and drainage, debridement, and medication of tissue by scaling and root planing procedure with
the canal system, antibiotics are not required gener- irrigation removes the infectious foci and resolves
ally [31,32]. In the event of systemic complications, the inflammation. The main objective would be to
such as fever, lymphadenopathy, or cellulitis or in disrupt the biofilm mechanically.
an immunocompromised patient, antibiotics may be
prescribed in addition to drainage of infection. [32]. The interrelationship between periodontitis and gly-
cemic control may be considered bidirectional [36].
Anyibiotics in Periodontal practice Oral hygiene education and mechanical debride-
ment of plaque and calculus combined with regular
Periodontitis is a bacterial infection and this has maintenance is important. When possible, a HbA1c
been used as a justification for the repeated routine of less than 10% should be established before sur-
use of antibiotics in periodontology. But the clinical gical treatment is performed and systemic antibiot-
relevance of bacteria being present in the tissues ics are not needed routinely. Also, periodontal treat-
is still not clearly defined in periodontal infections ment seems to improve glycemic control [37,38], It
and it is inappropriate to make clinical treatment was found that additional use of doxycycline did not
such as to use adjunctive systemic antibiotics on offer significant benefit in glycemic control [37], but
this premise alone. Montiero et al., [33] conducted when doxycycline was used, the topical local deliv-
a survey regarding the use of systemic antibiotics ery of doxycycline offered better glycemic control
by dentists for periodontal diseases and concluded (decrease by 10.5%) [39] than systemic doxycycline
that many dentists still use systemic antibiotics in- (decrease by 4.7%) [40].
correctly, without regard to evidence in published
literature, for inappropriate indications and using Aggressive periodontal diseases
inappropriate protocols that are ineffective in peri-
odontal therapy. There is considerable controversy Systemic therapy for treatment of the periodontal
on the use of microbial testing in periodontology. condition in conjunction with local therapy is indi-
cated in patients with aggressive periodontitis to have systemic complications. [35,46]. However, in
eliminate the bacteria that invade the gingival tis- patients with immunologic deficiencies or patients
sues and can repopulate the pocket after scaling with evidence of spread beyond the gingival tissues
and root planing. The use of antibiotics is beneficial as in necrotizing ulcerative periodontitis (NUP) then
only after the biofilm has been disrupted by ap- systemic antibiotics are indicated especially when
propriate mechanotherapy and antibiotics should be local root planing and curettage is not possible im-
used only after proper mechanotherapy has been mediately. [35]. Regular daily follow up and debride-
used and has been unsuccessful. The use of combi- ment with irrigation is required for management of
nation of amoxicillin and metronidazole in aggres- this lesion.
sive periodontal diseases is well supported [41–44],
however well designed controlled clinical trials are Necrotizing lesions of the gingiva and periodontium
limited as shown in a recent review [45]. can progress dramatically in Human Immunodefi-
ciency Virus (HIV) positive patients, thus it is nec-
Acute lesions of gingiva/periodontium essary to utilize thorough local therapy combined
with local use of antimicrobial mouthwashes such
The two most common acute gingival infections are as chlorhexidine and meticulous oral hygiene by the
necrotizing ulcerative gingivitis (NUG) and herpetic patient. Systemic antibiotics may be used especially
gingivostomatitis. Herpetic gingivostomatitis is a viral when systemic complications ensue or anticipated.
infection but may be complicated by superinfection Whenever possible, antibiotics should be avoided
with bacteria. These diseases occur most often in in significantly immunocompromised individuals to
healthy patients, but patients with depressed immu- minimize the risk of opportunistic infections (i.e.,
nologic responses have an increased risk for these candidiasis), superinfection, and micro-organism
gingival entities. Both may appear similar and the drug resistance [35,46,47].
treatment by debridement is effective for NUG but
may exacerbate herpetic gingivostomatitis. On the Periodontal abscess
other hand, antiviral therapy is effective for herpetic
gingival lesions but not for NUG. [35]. Periodontal abscesses can often be managed by
curetting the pocket under local anaesthesia to re-
Necrotizing lesions cause extensive tissue destruc- move plaque or any other aetiologic material. The
tion and necrosis. The treatment is mainly removal use of systemic antibiotics may be indicated when
of the necrotic tissue with pain control. Antibiotics patients have elevated temperatures or show signs
are not recommended in NUG patients who do not of cellulitis and have systemic disease/immuno-
8 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
compromised condition. [35,47]. Antibiotic therapy or the foreign material (membranes). Even though
alone without subsequent drainage and subgingival studies seem to suggest no additional benefit [49–
scaling is contraindicated. [35]. 52], current practice recommends use of antibiotics
in this scenario. [35]. High dose for a short term,
Periodontal surgeries would be beneficial not exceeding 5 days, would
be sufficient in most instances [35]. Consideration
Systemic antibiotics are generally used after recon- for peri-implant infections are tabulated in Table 6.
structive periodontal therapy, although definitive
information on the advisability of this measure is Topical antibiotics in Periodontology
still lacking [48–51].
There is a need to reduce the widespread and re-
Simple routine periodontal surgeries do not need peated use of topical antibiotics as advocated by
antibiotics in the postoperative period. Regenera- some manufacturers. Topical antimicrobial therapy
tive therapies using bone grafts, allografts and peri- should be used with same caution as applied to
odontal membranes sometimes require the use of systemic therapy. Their indications are similar to sys-
antibiotics to prevent infection of the bone graft temic antibiotic therapy in periodontology [13].
10 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
fected wounds and fractures/hardware should be administration is useful in cases done under general
treated as any maxillofacial infection and the same anaesthesia conveniently administered at the time
considerations are applicable including surgical re- of induction. The concept of antibiotic re-dosing
moval of the infectious foci with adjunctive use of may be applicable to complex surgeries of longer
antibiotics. durations which is rare in usual dental practice. Use
of multiple drugs have not been found to be benefi-
Concept of surgical prophylaxis in Oral cial [66]. To In patients who are allergic to penicillin,
and Maxillofacial Surgery clindamycin may be used [54,70–72].
12 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748
11. Cope A, Francis N, Wood F, Mann MK, Chestnutt IG. 32. Rosenberg PA. Endodontic Pain: Diagnosis, Causes, Prevention
Systemic antibiotics for symptomatic apical periodontitis and and Treatment. Springer; 2014.
acute apical abscess in adults. Cochrane Database Syst. Rev. 33. Monteiro AV, Ribeiro FV, Casarin RCV, Cirano FR, Pimentel SP,
2014;6:CD010136. Casati MZ. Evaluation of the use of systemic antimicrobial agents
12. Joseph J, Rodvold KA. The role of carbapenems in the treatment by professionals for the treatment of periodontal diseases. Braz
of severe nosocomial respiratory tract infections. Expert Opin. J Oral Sci 2013;12:285–91.
Pharmacother. 2008; 9:561–75. 34. Addy M, Martin MV. Systemic antimicrobials in the treatment of
13. Newman MG, Winkelhoff AJ van. Antibiotic and antimicrobial chronic periodontal diseases: a dilemma. Oral Dis 2003;9 Suppl
use in dental practice. Quintessence Pub Co.; 2001. 1:38–44.
14. Bratton TA, Jackson DC, Nkungula-Howlett T, Williams CW, 35. Newman MG, Takei H, Klokkevold PR, Carranza FA. Carranza’s
Bennett CR. Management of complex multi-space odontogenic Clinical Periodontology. Elsevier Health Sciences; 2011.
infections. J Tenn Dent Assoc 2002;82:39–47. 36. Taylor GW. Bidirectional interrelationships between diabetes
15. M.D JRH, Tucker MR. Contemporary Oral and Maxillofacial and periodontal diseases: an epidemiologic perspective. Ann
Surgery. Elsevier Science Health Science Division; 2013. Periodontol Am Acad Periodontol 2001;6:99–112.
16. Peterson LJ. Contemporary management of deep infections of 37. O’Connell PAA, Taba M, Nomizo A, Foss Freitas MC, Suaid FA,
the neck. J Oral Maxillofac Surg 1993;51:226–31. Uyemura SA, et al. Effects of periodontal therapy on glycemic
17. Poveda Roda R, Bagán JV, Sanchis Bielsa JM, Carbonell Pastor E. control and inflammatory markers. J Periodontol 2008;79:774–
Antibiotic use in dental practice: A review. Med. Oral Patol. Oral 83.
Cir. Bucal Internet 2007;12:186–92. 38. Teeuw WJ, Gerdes VEA, Loos BG. Effect of Periodontal
18. Brescó-Salinas M, Costa-Riu N, Berini-Aytés L, Gay-Escoda C. Treatment on Glycemic Control of Diabetic Patients A systematic
Antibiotic susceptibility of the bacteria causing odontogenic review and meta-analysis. Diabetes Care 2010;33:421–7.
infections. Med Oral Patol Oral Cir Bucal 2006;11:E70–75. 39. Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata
19. Bratton TA, Jackson DC, Nkungula-Howlett T, Williams CW, K, Makino H, et al. The effect of antimicrobial periodontal
Bennett CR. Management of complex multi-space odontogenic treatment on circulating tumor necrosis factor-alpha and
infections. J. Tenn. Dent. Assoc. 2002;82:39–47. glycated hemoglobin level in patients with type 2 diabetes. J
20. Mani N, Gross CH, Parsons JD, Hanzelka B, Müh U, Mullin S, Periodontol 2001;72:774–8.
et al. In Vitro Characterization of the Antibacterial Spectrum 40. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW,
of Novel Bacterial Type II Topoisomerase Inhibitors of the Dunford RG, et al. Treatment of periodontal disease in diabetics
Aminobenzimidazole Class. Antimicrob Agents Chemother reduces glycated hemoglobin. J Periodontol 1997;68:713–9.
2006;50:1228–37. 41. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth
21. Miloro M, Larsen P. Peterson’s Principles of Oral and Maxillofacial disinfection and systemic antimicrobial therapy in generalized
Surgery. PMPH-USA; 2004. aggressive periodontitis: a randomized, placebo-controlled trial.
22. Daramola OO, Flanagan CE, Maisel RH, Odland RM. Diagnosis J Clin Periodontol 2012;39:284–94.
and treatment of deep neck space abscesses. Otolaryngol.- 42. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden
-Head Neck Surg. Off. J. Am. Acad. Otolaryngol.-Head Neck U, Van der Weijden GA. Amoxicillin plus metronidazole in
Surg. 2009;141:123–30. the treatment of adult periodontitis patients. A double-blind
23. Lumley P. Penicillin does not provide effective pain relief for placebo-controlled study. J. Clin. Periodontol. 2001;28:296–
untreated irreversible pulpitis. Evid. Based Dent. 2002;3:72–72. 305.
24. Nagle D, Reader A, Beck M, Weaver J. Effect of systemic penicillin 43. Van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological and
on pain in untreated irreversible pulpitis. Oral Surg. Oral Med. clinical results of metronidazole plus amoxicillin therapy in
Oral Pathol. Oral Radiol. Endod. 2000;90:636–40. Actinobacillus actinomycetemcomitans-associated periodontitis.
25. Peedikayil F. Antibiotics: Use and misuse in pediatric dentistry. J J Periodontol 1992;63:52–7.
Indian Soc Pedod Prev Dent 2011;29:282. 44. Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A.
26. Shetty DN. Mid treatment flare-ups in endodontics –A dilemma. Clinical and microbiological effects of different antimicrobials
EndodontologyIndian Endod. Soc. [Internet]. 2005 [cited 2014 on generalized aggressive periodontitis. J Clin Periodontol
Jun 23];17. Available from: http://eprints.manipal.edu/1192/ 2006;33:254–64.
27. Rosenberg PA. Clinical strategies for managing endodontic pain. 45. Ahuja A, Baiju C, Ahuja V. Role of antibiotics in generalized
Endod. Top. 2002;3:78–92. aggressive periodontitis: A review of clinical trials in humans. J
28. Dibart S. Practical Advanced Periodontal Surgery. John Wiley & Indian Soc Periodontol 2012;16:317.
Sons; 2011. 46. Burket LW. Burket’s Oral Medicine: Diagnosis and Treatment.
29. Ingle JI, Bakland LK, Baumgartner JC. Ingle’s Endodontics 6. PMPH-USA; 2003.
PMPH-USA; 2008. 47. Lindhe J, Lang NP, Karring T. Clinical Periodontology and Implant
30. Pedlar J, Frame JW. Oral and Maxillofacial Surgery: An Objective- Dentistry, 2 Volumes. Wiley; 2008.
Based Textbook. Elsevier Health Sciences; 2007. 48. Heitz-Mayfield L. Systemic antibiotics in periodontal therapy.
31. Mitchell L, Mitchell DA. Oxford Handbook of Clinical Dentistry. Aust. Dent. J. 2009;54:S96–S101.
Oxford University Press; 2009.
49. Minabe M, Kodama T, Kogou T, Fushimi H, Sugiyama T, Takeuchi 65. Lovato C, Wagner JD. Infection rates following perioperative
K, et al. Clinical significance of antibiotic therapy in guided tissue prophylactic antibiotics versus postoperative extended regimen
regeneration with a resorbable membrane. Periodontal Clin prophylactic antibiotics in surgical management of mandibular
Investig, Off Publ Northeast. Soc Periodontists. 2001;23:20–30. fractures. J Oral Maxillofac Surg , Off J Am. Assoc Oral Maxillofac
50. Sculean A, Blaes A, Arweiler N, Reich E, Donos N, Brecx M. Surg 2009;67:827–32.
The effect of postsurgical antibiotics on the healing of intrabony 66. Topazian RG, Goldberg MH, Hupp JR. Oral and maxillofacial
defects following treatment with enamel matrix proteins. J infections. W.B. Saunders Co.; 2002.
Periodontol 2001;72:190–5. 67. Misch CE. Contemporary Implant Dentistry. Elsevier Health
51. Loos BG, Louwerse PHG, Van Winkelhoff AJ, Burger W, Sciences; 2008.
Gilijamse M, Hart A a. M, et al. Use of barrier membranes and 68. Adaman F, Goksen F, Grolin J, O’Brien M, Seippel O, Zenginobuz
systemic antibiotics in the treatment of intraosseous defects. J EU. Integrating and Articulating Environments. CRC Press; 2003.
Clin Periodontol 2002;29:910–21. 69. Roy J. An Introduction to Pharmaceutical Sciences: Production,
52. Powell CA, Mealey BL, Deas DE, McDonnell HT, Moritz AJ. Chemistry, Techniques and Techn70. Fine DH, Hammond BF,
Post-surgical infections: prevalence associated with various Loesche WJ. Clinical use of antibiotics in dental practice. Int J
periodontal surgical procedures. J Periodontol 2005;76:329–33. Antimicrob Agents 1998;9:235–8.
53. Paul P, Williams B. Brunner & Suddarth’s Textbook of Canadian 71. Peterson LJ. Antibiotic prophylaxis against wound infections in
Medical-surgical Nursing. Lippincott Williams & Wilkins; 2009. oral and maxillofacial surgery. J Oral Maxillofac Surg, Off J Am
54. Guerrero JS. Use of prophylactic antibiotic therapy in oral surgical Assoc Oral Maxillofac Surg 1990;48:617–20.
procedures: a critical review. J Calif. Dent Assoc 2008;36:943– 72. Poveda Roda R, Bagan JV, Sanchis Bielsa JM, Carbonell Pastor E.
50. Antibiotic use in dental practice. A review. Med Oral Patol Oral
55. Kaczmarzyk T. Abuse of antibiotic prophylaxis in third molar Cir Bucal 2007;12:E186–192.
surgeries. J. Oral Maxillofac. Surg. Off. J. Am. Assoc. Oral 73. Davies A, Epstein J. Oral Complications of Cancer and Its
Maxillofac. Surg. 2009;67:2551–2. Management. Oxford University Press; 2010.
56. Sancho-Puchades M, Herráez-Vilas JM, Berini-Aytés L, Gay- 74. Peterson DE, Sonis ST. Oral Complications of Cancer
Escoda C. Antibiotic prophylaxis to prevent local infection in Chemotherapy. Springer Science & Business Media; 1983.
Oral Surgery: use or abuse? Med. Oral Patol. Oral Cir Bucal 75. National Guideline Clearinghouse (NGC). Guideline on
2009;14:E28–33. antibiotic prophylaxis for dental patients at risk for infection.
57. Lodi G, Figini L, Sardella A, Carrassi A, Del Fabbro M, Furness S. [Internet]. Available from: http://www.guideline.gov/content.
Antibiotics to prevent complications following tooth extractions. aspx?id=34766
Cochrane Database Syst. Rev. [Internet]. John Wiley & Sons, Ltd; 76. Oral Complications of Chemotherapy and Head/Neck Radiation
1996 [cited 2014 Jun 24]. Available from: http://onlinelibrary. (PDQ® [Internet]. Natl. Cancer Inst. [cited 2014 Jul 29]. Available
wiley.com/doi/10.1002/14651858.CD003811.pub2/abstract from: http://www.cancer.gov/cancertopics/pdq/supportivecare/
58. Esposito M, Grusovin MG, Worthington HV. Interventions for oralcomplications/HealthProfessional/page3
replacing missing teeth: antibiotics at dental implant placement 77. Centers for Disease Control and Prevention, Infectious Disease
to prevent complications. Cochrane Database Syst. Rev. Society of America, American Society of Blood and Marrow
2013;7:CD004152. Transplantation. Guidelines for preventing opportunistic
59. Ahmad N, Saad N. Effects of Antibiotics on Dental Implants: A infections among hematopoietic stem cell transplant recipients.
Review. J. Clin. Med. Res. 2012;4:1–6. MMWR Recommendation . Wkly Rep Recomm. Rep Cent Dis
60. Tan WC, Ong M, Han J, Mattheos N, Pjetursson BE, Tsai AY-M, et Control 2000;49:1–125, CE1–7.
al. Effect of systemic antibiotics on clinical and patient-reported 78. Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB,
outcomes of implant therapy - a multicenter randomized Strausbaugh LJ. Decision-Making on the Use of Antimicrobial
controlled clinical trial. Clin Oral Implants Res 2014;25:185–93. Prophylaxis for Dental Procedures: A Survey of Infectious Disease
61. Antibiotic and Antimicrobial Use in Dental Practice, Second Consultants and Review. Clin Infect Dis 2002;34:1621–6.
Edition [Internet]. [cited 2014 Jun 23]. Available from: http:// 79. Bobhate P, Pinto RJ. Summary of the new guidelines for
w w w.quintpub.com /display_detail.php3?psku= B3970#. prevention of Infective Endocarditis: Implications for the
U6hpoHJmOW8 developing countries. Ann Pediatr Cardiol 2008;1:56–8.
62. Chole RA, Yee J. Antibiotic prophylaxis for facial fractures. A 80. Centre for Clinical Practice at NICE (UK). Prophylaxis Against
prospective, randomized clinical trial. Arch Otolaryngol Head Infective Endocarditis: Antimicrobial Prophylaxis Against
Neck Surg 1987;113:1055–7. Infective Endocarditis in Adults and Children Undergoing
63. Lauder A, Jalisi S, Spiegel J, Stram J, Devaiah A. Antibiotic Interventional Procedures [Internet]. London: National Institute
prophylaxis in the management of complex midface and frontal for Health and Clinical Excellence (UK); 2008 [cited 2014 Jul 14].
sinus trauma. The Laryngoscope 2010;120:1940–5. Available from: http://www.ncbi.nlm.nih.gov/books/NBK51789/
64. Lauder A, Devaiah A. Antibiotic prophylaxis in the surgical 81. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I,
management of facial trauma. The Laryngoscope 2010;120 et al. Guidelines on the prevention, diagnosis, and treatment of
Suppl 4:S232. infective endocarditis (new version 2009) The Task Force on the
14 Received 18 July 2014; accepted 22 August 2014 This article is available from: www.iajaa.org
THE INTERNATIONAL ARABIC JOURNAL 2014
OF ANTIMICROBIAL AGENTS Vol. 4 No. 2:1
doi: 10.3823/748